Fortitude Family Office »

Leap Therapeutics shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Leap Therapeutics (CYPH) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2025-12-31 $210 182 1.16

More positions owned by Fortitude Family Office

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard 0-3 Month Treasury Bill Etf Etf (VBIL)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Apple Stock (AAPL)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Knight-swift Transn Hldgs Inc Cl A Stock (KNX)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Vanguard S&p 500 Etf Etf (VOO)
Vanguard Mid-cap Etf Etf (VO)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Invesco Senior Loan Etf Etf (BKLN)
Ishares Core S&p Mid-cap Etf Etf (IJH)

View all positions for Fortitude Family Office

Top funds holding Leap Therapeutics

Gilead Sciences
Vanguard Group
HighTower Advisors
Simplify Asset Management
Geode Capital Management
Jane Street
State Street Corporation
BlackRock
Hrt Financial
Texas Capital Bank Wealth Management Services
Two Sigma Advisers
Susquehanna International
Key Client Fiduciary Advisors
Citadel Advisors
Two Sigma Investments

View all funds holding Leap Therapeutics